Arthur J. McCullough

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.5K citations

Nafld Activity Score, Diagnosis, Pathology +24

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine · 2010 · 3.2K citations · Full text

Nonalcoholic Fatty Liver Disease

Giulio Marchesini, Mara Brizi, Giampaolo Bianchi et al. · Diabetes · 2001 · 2.6K citations · Full text

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

Hepatology, Medicine, Liver Physiology +7

Association of nonalcoholic fatty liver disease with insulin resistance

Giulio Marchesini, Mara Brizi, Antonio Maria Morselli‐Labate et al. · The American Journal of Medicine · 1999 · 1.6K citations

Insulin Resistance, Obesity, Metabolic Syndrome +12